Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)

Authors not listed

OccuLogix · 1999

Abstract

AMD is a progressive disease of the retina which is nourished by a network of tiny blood vessels. There is evidence to suggest that the flow of nutrients to the retina is impaired in patients with AMD. Rheopheresis blood filtration uses blood filters that deplete excesses of large proteins, fats and other substances from the blood, improving blood flow to the macula, potentially improving vision.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Anonymous. (1999). Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD). <em>OccuLogix</em>. https://clinicaltrials.gov/study/NCT00078221
Vancouver
Anonymous. Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD). OccuLogix. 1999.
BibTeX
@misc{anon1999Rheoph, title = {Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)}, author = {Anonymous}, journal = {OccuLogix}, year = {1999}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings